How drugs works.

Drug coins

Each coin in the drugs catalogue is intended to track a documented price reference for its drug. XAN is the Xanax reference coin; a market such as CHILL / XAN trades in XAN. The launched token has its own market price in XAN, while XAN targets the drug-price reference.

The drug reference price, the reference coin’s executable trading price, and the launched token’s price are separate values. The intended tracking mechanism keeps the reference coin close to its benchmark; trading in the launched token determines how many reference coins it is worth. Today’s displayed quotes are fixed demo inputs, not sourced drug prices.

For a demo basket, the reference unit uses the selected coins’ weighted quotes. It is a calculation inside the demo, not a minted basket asset.

How price tracking works Planned

Each drug reference coin is intended to trade against USDG around its published benchmark. An on-chain feed records the reference, funded liquidity supplies buy and sell quotes, and a keeper updates the feed and reprices the pools when the reference changes.

The benchmark identifies the drug, reference unit, region, currency, source, and reference date. Published street-price estimates remain fixed between documented revisions. The catalogue will distinguish the published reference from the coin’s executable trading price and show when the source was last reviewed.

Launching a market

Open Launch, set the token’s identity, choose its pair, and review the purchase before creating it. The first purchase and market creation succeed together in the demo.

The review shows estimated tokens, the fee, your remaining balance, and the market cap after the first buy. Your first purchase receives tokens at the curve’s changing price, so the final cap will already be above the opening value.

The bonding curve

The demo uses a constant-product model with virtual reserves. Buys increase price; sells decrease it. Progress measures the net share of the curve allocation sold, so selling can reduce progress before completion.

A purchase that reaches the end uses only the remaining inventory. Its unused budget stays in your demo wallet, with no fee charged on that unused amount. Virtual reserves are pricing inputs, not extra tokens or deposited funds.

Reference quotes stay constant in this demo. A future change in a pair’s USD value would change the USD display; it would not reset the launch’s pair-denominated curve.

Trading

The demo wallet starts with $25,000, enough to explore a full launch. Buy amounts are USD budgets; sell amounts are token quantities. For curve trades, the app converts the budget into the market’s reference unit and includes both the fee and price impact in the quote.

Every completed trade updates your holdings, balance, market volume, and fee ledger. Newly launched markets also update curve price and progress. Preloaded example markets retain illustrative fixed quotes and chart histories.

Use Max to fill the available balance or holding. If a quote is invalid or funds are insufficient, the trade does not execute. Quotes are simulated immediately; there is no network transaction, gas charge, or swap route.

Migration Planned

The intended destination is Uniswap v4: reserved tokens and raised pair coins seed liquidity, retaining the selected fee. Basket launches would need a pool for each funded leg. Liquidity placement must preserve the final curve price while accounting for all raised assets.

Pool deployment, position ranges, liquidity restrictions, and retry behavior need to be implemented and verified in the drugs contracts before they can be described as live guarantees.

Trading fees

The selected rate applies to each executed trade. The allocation is:

These shares divide the fee, not the purchase amount. There is no separate creator share for a new drugs launch.

Holder rewards Planned

The holder allocation is designed to be balance-weighted and paid in the market’s drug reference coins. Holders of a CHILL / XAN market would receive XAN; holders of a market paired with WEED would receive WEED. Eligible balances, excluded addresses, payout thresholds, and distribution scheduling still need contract and service rules.

Today, the market detail screen shows the simulated allocation accumulated during your session. It is not a claimable balance, an executed payment, or an earnings projection.

$DRUGS Planned

$DRUGS is the working symbol for the proposed protocol token. The demo tracks a buyback allocation, but no $DRUGS token, swap, burn, or treasury transaction has been deployed by this app.

A verified contract address and the actual buyback rules will be published here before the app offers those features. There is no token sale or purchase link in this documentation.

Market details

A launch can include an image, description, website, X profile, and Telegram link. The review lets you check them before publication in your current session. The default image is the selected drug’s pixel art.

Accepted uploads are PNG, JPEG, and WebP up to 5 MB. Your image stays in the browser session; it is not uploaded to permanent storage. Token identity, links, and basket weights cannot be edited after the demo market is created.

The intended on-chain version will publish content-addressed metadata and record its URI at creation. That storage and contract integration is still pending.

Contracts & status

No contract addresses from another exchange are drugs addresses. The app does not have a contract audit to publish yet.

Common questions